Showing results (1721-1730 of 3,014) with videos related to

Sort By:
Pageof 302
Plants (Basel, Switzerland)|March 17, 2025
An In Vitro Phytohormone Survey Reveals Concerted Regulation of the Cannabis Glandular Trichome Disc Cell ProteomeNicolas Dimopoulos, Qi Guo, Lei Liu, et al.
Biofabrication|August 13, 2024
Laser-assisted bioprinting of targeted cartilaginous spheroids for high density bottom-up tissue engineeringGabriella Nilsson Hall, Yuchao Fan, Bertrand Viellerobe, et al.
Biomedicines|November 27, 2025
Epigenetics in Ovarian Cancer: A Review of Current Knowledge and Future PerspectivesNikolaos Dedes, Michalis Liontos, Dimitrios Haidopoulos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2014
Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomasRevekka Gyftaki, Gyftaki Revekka, Christina Liacos, et al.
Frontiers in Oncology|December 19, 2022
Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysisAngeliki Andrikopoulou, Eleni Zografos, Kleoniki Apostolidou, et al.
Atherosclerosis|December 3, 2010
Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stressDimitris Tousoulis, Ioannis Andreou, Marinos Tsiatas, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patientsEvangelos Terpos, Anna Tasidou, Evangelos Eleftherakis-Papaiakovou, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 14, 2021
Overweight/Obesity and Monoclonal Gammopathy of Undetermined SignificanceRebecca Georgakopoulou, Angeliki Andrikopoulou, Theodoros N Sergentanis, et al.
The Journal of Clinical Psychiatry|March 20, 2008
Vardenafil in the treatment of erectile dysfunction in outpatients with chronic schizophrenia: a flexible-dose, open-label studyCharalampos I Mitsonis, Panagiotis A Mitropoulos, Nikolaos P Dimopoulos, et al.
Haematologica|May 30, 2013
Phase II study of bortezomib-dexamethasone alone or with added cyclophosphamide or lenalidomide for sub-optimal response as second-line treatment for patients with multiple myelomaMeletios A Dimopoulos, Meral Beksac, Lotfi Benboubker, et al.
Pageof 302